Zobrazeno 1 - 10
of 599
pro vyhledávání: '"AMOR R"'
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303289 (2024)
Malaria and Human Immunodeficiency Virus infections are among the top 10 causes of death in low income countries. Furthermore, many medicines used in these treatment areas are substandard, which contributes to the high death rate. Using a monitoring
Externí odkaz:
https://doaj.org/article/4f6baeb5403d437b9422813e8b439ed6
Autor:
Amor R Cáceres-Pérez, Mohamed B El Kory, Javier Suárez-González, Mabel Soriano, M Magdalena Echezarreta, Ana Santoveña-Estévez, José B Fariña
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282023 (2023)
The quality of drug products may be affected from manufacture to dispensing, particularly at high temperature and humidity as in Mauritania. This country is not included in the World Health Organization reports on poor quality products due to the lac
Externí odkaz:
https://doaj.org/article/917ac85368884037a4e4dc4f3d0aa046
Autor:
Javier Suárez-González, Amor R. Cáceres-Pérez, Alexis Oliva, Ana Santoveña-Estévez, José B. Fariña
Publikováno v:
Molecules, Vol 27, Iss 20, p 7141 (2022)
Drug products used for treating tuberculosis are one of the most widely reported medicines to be classified as falsified or substandard in low- and middle-income countries, representing a major hazard to health. The aim of this study was, firstly, to
Externí odkaz:
https://doaj.org/article/f087b76131b640bfbf596611d09d36d2
Autor:
Ana Santoveña-Estévez, Javier Suárez-González, Amor R. Cáceres-Pérez, Zuleima Ruiz-Noda, Sara Machado-Rodríguez, Magdalena Echezarreta, Mabel Soriano, José B. Fariña
Publikováno v:
Pharmaceutics, Vol 12, Iss 2, p 195 (2020)
(1) Background: First-line antituberculosis treatment in paediatrics entails the administration of Isoniazid, Pyrazinamide, and Rifampicin. This study examines the possibility of developing a combined dose liquid formulation for oral use that would f
Externí odkaz:
https://doaj.org/article/201c5719e161427888c0b4ba324a458b
Autor:
Cáceres-Pérez, Amor R.1,2,3 (AUTHOR), Suárez-González, Javier1,3 (AUTHOR) jsuarezg@ull.edu.es, Santoveña-Estévez, Ana1,3 (AUTHOR), Fariña, José B.1,3 (AUTHOR)
Publikováno v:
PLoS ONE. 5/9/2024, Vol. 19 Issue 5, p1-19. 19p.
Autor:
Ben Amor, L., Lachal, J., Menard, M.-L., Pelletier, W., Mac Dermott, V., Ben Amor, R., Sanchez, I., Lapointe, L., Bouchard, P., Rousseau, B., Ricard, N.
Publikováno v:
In L'Encéphale June 2023 49(3):211-218
Autor:
Suárez-González, Javier, Magariños-Triviño, María, Díaz-Torres, Eduardo, Cáceres-Pérez, Amor R., Santoveña-Estévez, Ana, Fariña, José B.
Publikováno v:
In Journal of Drug Delivery Science and Technology December 2021 66
Autor:
Cáceres-Pérez, Amor R.1,2,3 (AUTHOR), El Kory, Mohamed B.4 (AUTHOR), Suárez-González, Javier1,3 (AUTHOR) jsuarezg@ull.edu.es, Soriano, Mabel1,3 (AUTHOR), Echezarreta, M. Magdalena1,3 (AUTHOR), Santoveña-Estévez, Ana1,3 (AUTHOR), Fariña, José B.1,3 (AUTHOR)
Publikováno v:
PLoS ONE. 3/16/2023, Vol. 17 Issue 3, p1-18. 18p.
Autor:
Laroza, Fiehl Amor R.1 (AUTHOR) frlaroza@alum.up.edu.ph
Publikováno v:
International Journal of Construction Management. May2024, p1-11. 11p. 10 Charts.
Autor:
Suárez-González, Javier1,2 (AUTHOR), Cáceres-Pérez, Amor R.1,2,3 (AUTHOR), Oliva, Alexis1,2 (AUTHOR) amoliva@ull.edu.es, Santoveña-Estévez, Ana1,2 (AUTHOR), Fariña, José B.1,2 (AUTHOR)
Publikováno v:
Molecules. Oct2022, Vol. 27 Issue 20, p7141-N.PAG. 15p.